CHF 40,000 for a VR-based ADHD treatment, a platform for fashion content creation, and a non-invasive cancer detection

sefit health: Strengthening sensory filters for better social integration
The startup addresses impaired stimulus filtering, a condition common in individuals with Attention Deficit Hyperactivity Disorder (ADHD), Autismus Spectrum Disorder (ASD), and migraines. People affected by this struggle to manage sensory input, leading to overwhelming experiences that disrupt social interactions, education, and work.
Founded by Elena Börlin and Eric Nerger, the startup leverages its expertise in medical informatics and clinical research to develop a VR-based tool aimed at helping those with impaired stimulus filtering. This solution is a non-pharmacological addition or alternative compared to the off-label medication which can support patients suffering from impaired stimulus filtering. Our goal is to empower the patients to manage sensory overload and stress more effectively. The Total Addressable Market (TAM) for this solution is 120 million individuals across DACH, USA, and Canada, highlighting a growing demand for non-pharmaceutical solutions.
They will use the Venture Kick funds to finance digital biomarkers for clinical studies, including purchasing 30 FitBit smartwatches. The remaining amount will be allocated toward the support of acquiring ISO 13485.

Shootify Labs: Revolutionizing fashion content creation
Fashion brands face a significant challenge in producing high-quality visual content rapidly and cost-effectively. Traditional photo shoots are expensive and time-consuming, making it difficult for brands to keep pace with fast fashion cycles and the constant demand for fresh, engaging content.
Founded by Luca Ambrosini, Felipe Cardoso, and Andrea Ravano, Shootify is an innovative platform that revolutionizes fashion content creation through a custom Generative AI model tailored specifically for the industry. Their technology prioritizes unparalleled accuracy in garment specifications and fitting—elements that are fundamental for fashion brands and their customers. By enabling the instant generation of precise, high-quality images, Shootify not only streamlines the content creation process but also opens new possibilities for enhancing customer experience. The global fashion market, worth over $2 trillion, provides a vast arena for Shootify's scalable and industry-specific solution.
The Venture Kick Stage 1 funds will be instrumental in helping Shootify sharpen its market entry strategy. We aim to determine the optimal client focus—be it large brands, small brands, agencies, or direct partnerships—and identify niche segments where our technology can make the most immediate impact.

zuriEV: Breakthrough Non-Invasive Cancer Detection & Monitoring
Tumors need to be detected earlier and more precise - especially those where limited therapeutic options exist at later stages, such as pancreatic, lung, liver, kidney, and brain tumors. Currently, diagnosis is expensive, inaccurate, and occurs too late. 
zuriEV has discovered a highly sensitive and specific, multi-omics compatible, pan-tumor liquid biopsy platform allowing the detection of tumor-specific EVs with a high specificity and sensitivity. With our scalable biopsy platform, they can detect, isolate, and quantify tumor marker-carrying EVs directly from blood. This opens the door to the multi-billion market of early tumor diagnosis and subsequent treatment monitoring – especially in the US and Europe. The founding team consists of a group of first-time founders and serial entrepreneurs, based in Zürich and deeply embedded in leading Swiss academic research institutions: CSO PD Dr. med. Dr. sc. nat. Tobias Weiss, CEO Dr. Yanan Zhang, and CTO Senior Scientist Dr. Stavros Stavrakis.
The Venture Kick funds will be used to strengthen ongoing research and provide the basis for company formation.